Cargando…
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
Autores principales: | Al Jurdi, Ayman, Gassen, Rodrigo B., Borges, Thiago J., Lape, Isadora T., Morena, Leela, Efe, Orhan, Solhjou, Zhabiz, El Fekih, Rania, Deban, Christa, Bohan, Brigid, Pattanayak, Vikram, Kotton, Camille N., Azzi, Jamil R., Riella, Leonardo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006415/ https://www.ncbi.nlm.nih.gov/pubmed/35429496 http://dx.doi.org/10.1016/j.kint.2022.04.009 |
Ejemplares similares
-
Non-Invasive Monitoring for Rejection in Kidney Transplant Recipients After SARS-CoV-2 mRNA Vaccination
por: Al Jurdi, Ayman, et al.
Publicado: (2022) -
Tixagevimab/cilgavimab pre-exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
por: Al Jurdi, Ayman, et al.
Publicado: (2022) -
Factors Associated With Reduced Anti-SARS-CoV-2 Antibody Responses After mRNA Vaccination in Kidney Transplant Recipients on Belatacept
por: Morena, Leela, et al.
Publicado: (2022) -
Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect
por: Al Jurdi, Ayman, et al.
Publicado: (2023) -
Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution
por: Halawi, Ahmad, et al.
Publicado: (2023)